Carregant...
Establishment of a mouse model of cancer cachexia with spleen deficiency syndrome and the effects of atractylenolide I
Cancer cachexia is a multifactorial metabolic syndrome that affects ∼50%–80% of cancer patients, and no effective therapy for cancer cachexia is presently available. In traditional Chinese medicine, a large portion of patients with cancer cachexia was diagnosed as spleen deficiency syndrome and trea...
Guardat en:
| Publicat a: | Acta Pharmacol Sin |
|---|---|
| Autors principals: | , , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Springer Singapore
2019
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7470874/ https://ncbi.nlm.nih.gov/pubmed/31341256 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41401-019-0275-z |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|